Friday 6 November 2026 Export BBIO’s income statement to Excel — free account

BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $502.1 million, up 126.3% from fiscal 2024.

Revenue: +192.6%
EPS: +55.8%
Free cash flow: +60.5%
Total debt: +4.21%

Quarter to September 2026, against a year earlier

73.98 0.29 −0.39%

Follow BBIO

Alert me

Market cap: $14.5B
P/E: 0.0×
Fwd P/E: −27.5×
Dividend yield: —
F-score: 3/9
Altman Z: −3.45
Beneish M: 8.17
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

BridgeBio Pharma, Inc. (BBIO) P/B ratio

Alert me on P/B ratio

BridgeBio Pharma, Inc. has no meaningful P/B ratio: its trailing twelve-month book value is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 80.3× (February 2021) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/BBIO/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="BridgeBio Pharma, Inc. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/BBIO/metrics/pb-ratio">BridgeBio Pharma, Inc. (BBIO) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	0.0×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	79.0×	915.53%
FY2019	7.8×	—

Period	P/B ratio	Change
Sep 2026	0.0×	—
Jun 2026	0.0×	—
Mar 2026	0.0×	—
Dec 2025	0.0×	—
23 more quarters	Free account

Against its own ten years

Low 0.0× High 80.3×

Ten-year median 0.0×

Current reading's percentile 76

Company	P/B ratio
HALO Halozyme Therapeutics, Inc. compare	n/m
BBIO BridgeBio Pharma, Inc.	n/m
BMRN BioMarin Pharmaceutical Inc. compare	1.7×
JAZZ Jazz Pharmaceuticals PLC compare	3.5×
TECH Bio-Techne Corp compare	5.4×
KYMR Kymera Therapeutics, Inc. compare	7.8×
EXEL Exelixis, Inc. compare	9.3×
ASND Ascendis Pharma A/S compare	9.8×
SMMT Summit Therapeutics PLC compare	17.8×
Biotechnology industry median	2.0×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

BridgeBio Pharma, Inc. (BBIO) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on BBIO

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on BBIO

Stockrow Weekly